Entyvio 108 mg solution for injection in pre-filled pen

DRUG2 trials

Sponsors

Takeda Development Center Americas Inc., Varsinais-Suomen hyvinvointialue

Conditions

Crohn´s diseaseUlcerative ColitisUlcerative Colitis or Crohn’s Disease

Phase 3

A Phase 3b Extension Study to Evaluate the Long-Term Safety of Vedolizumab Subcutaneous in Pediatric Subjects With Ulcerative Colitis or Crohn’s Disease

RecruitingCTIS2023-508804-39-00

Takeda Development Center Americas Inc.Ulcerative Colitis or Crohn’s Disease

Start: 2025-10-15Target: 32Updated: 2026-01-23

Phase 4

Fecal microbiota transplantation in patients receiving infliximab and vedolizumab for ulcerative colitis: A randomized controlled trial

Not yet recruitingCTIS2024-520373-12-00

Varsinais-Suomen hyvinvointialueCrohn´s disease, Ulcerative Colitis

Target: 40Updated: 2025-01-21